Firefly Neuroscience (AIFF) Free Cash Flow (2010 - 2026)

Firefly Neuroscience's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 20.33% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$7.8 million, a 21.94% increase from a year earlier, with the FY2025 full-year figure at -$8.3 million, down 32.03% from the prior year.
• Free Cash Flow eased to -$2.0 million in Q1 2026 per AIFF's latest filing, from -$1.8 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $87103.0 in Q3 2022 and bottomed at -$5.0 million in Q3 2024.
• The 5-year median for Free Cash Flow is -$1.7 million (2025), against an average of -$1.7 million.
• Across the five-year window, Free Cash Flow jumped 125.38% in 2022 and plunged 2383.01% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at -$3.5 million in 2022, then soared by 85.62% to -$510000.0 in 2023, then slumped by 881.37% to -$5.0 million in 2024, then soared by 63.48% to -$1.8 million in 2025, then fell by 9.74% to -$2.0 million in 2026.
• Per Business Quant, the three latest AIFF Free Cash Flow figures stand at -$2.0 million (Q1 2026), -$1.8 million (Q4 2025), and -$1.6 million (Q3 2025).